1 |
Pachaly, P., Treitner, A. and Sin, K. S. (1996) Neue cumaringlykoside
aus Angelica gigas. Pharmazie 51, 57-61.
|
2 |
Perchenet, L. and Clement-Chomienne, O. (2000) Characterization
of mibefradil block of the human heart delayed rectifi er hKv1.5. J.
Pharmacol. Exp. Ther. 295, 771-778.
|
3 |
Ryu, K. S., Hong, N. D., Kim, N. J. and Kong, Y. Y. (1990) Studies on
the coumarin constituents of the root of Angelica gigas Nakai. Isolation
of decursinol angelate and assay of decursin angelate and
decursin. Korean J. Pharmcacogn. 21, 64-68.
과학기술학회마을
|
4 |
Shin, K. H., Han, J. M. and Lee, I. R. (1996) Effect of the constituents
of Angelica gigantis Radix on hepatic drug metabolizing enzymes.
Korean J. Pharmcacogn. 27, 323-327.
|
5 |
Snyders, D. J., Tamkun, M. M. and Bennett, P. B. (1993) A rapidly activating
and slowly inactivating potassium channel cloned from human
heart. Functional analysis after stable mammalian cell culture
expression. J. Gen. Physiol. 101, 513-543.
DOI
|
6 |
Wang, Z., Fermini, B. and Nattel, S. (1994) Rapid and slow components
of delayed rectifi er current in human atrial myocytes. Cardiovasc.
Res. 28, 1540-1546.
DOI
|
7 |
Yook, C. S. (1990) Coloured medicinal plants of Korea. pp. 390. Academy
Book, Seoul, Korea.
|
8 |
Fedida, D., Chen, F. S. and Zhang, X. (1998) The 1997 Stevenson
Award Lecture. Cardiac channel gating: cloned delayed rectifier mechanisms and drug modulation. Can. J. Physiol. Pharmacol. 76,
77-89.
DOI
|
9 |
Kang, S. Y., Lee, K. Y., Sung, S. H., Park, M. J. and Kim, Y. C. (2001)
Coumarins isolated from Angelica gigas inhibit acetyl cholinesterase:
Structure-activity relationships. J. Nat. Prod. 64, 683-685.
DOI
|
10 |
Jung, D. J., Porzel, A. and Huneck, S. (1991) Gigasol and other coumarines
from Angelica gigas. Phytochemistry 30, 710-712.
DOI
|
11 |
Kim, W. J., Lee, S. J., Choi, Y. D. and Moon, S. K. (2010) Decursin
inhibits growth of human bladder and colon cancer cells via apoptosis,
G1-phase cell cycle arrest and extracellular signal-regulated
kinase activation. Int. J. Mol. Med. 25, 635-641.
|
12 |
Kwak, Y. G., Kim, D. K., Ma, T. Z., Park, S. A., Park, H., Jung, Y. H.,
Yoo, D. J. and Eun, J. S. (2006) Torilin from Torilis japonica (Houtt.)
DC. blocks hKv1.5 channel current. Arch. Pharm. Res. 29, 834-839.
DOI
|
13 |
Kwak, Y. G., Navarro-Polanco, R. A., Grobaski, T., Gallagher, D. J.
and Tamkun, M. M. (1999) Phosphorylation is required for alteration
of Kv1.5 K+ channel function by the Kvbeta 1.3 subunit. J. Biol.
Chem. 274, 25355-25361.
DOI
|
14 |
Lee, H. J., Lee, H. J., Lee, E. O., Lee, J. H., Lee, K. S., Kim, K. H., Kim,
S. H. and Lu, J. (2009) In vivo anti-cancer activity of Korean Angelica
gigas and its major pyranocoumarin decursin. Am. J. Chin.
Med. 37, 127-142.
DOI
|
15 |
Lee, S., Kang, S. S. and Shin, K. H. (2002) Coumarins and a pyrimidine
from Angelica gigas roots. Nat. Prod. Sci. 8, 58-61.
|
16 |
Lee, S. H., Lee, Y. S., Jung, S. H., Shin, K. H., Kim, B. K. and Kang, S.
S. (2003) Anti-tumor activities of decursinol angelate and decursin
from Angelica gigas. Arch. Pharm. Res. 26. 727-730.
DOI
|
17 |
Eun, J, S., Kim, K. S., Kim, H. N., Park, S. A., Ma, T. Z., Lee, K. A.,
Kim, D. K., Kim, H. K., Kim, I. S., Jung, Y. H., Zee, O. P., Yoo, D. J.
and Kwak, Y. G. (2007) Synthesis of psoralen derivatives and their
blocking effect of hKv1.5 channel. Arch. Pharm. Res. 30, 155-160.
DOI
|
18 |
Choe, H., Lee, Y. K., Lee, Y. T., Choe, H., Ko, S. H., Joo, C. U., Kim,
M. H., Kim, G. S., Eun, J. S., Kim, J. H., Chae, S. W. and Kwak, Y.
G. (2003) Papaverine blocks hKv1.5 channel current and human
atrial ultrarapid delayed rectifier currents. J. Pharmacol. Exp. Ther. 304, 706-712.
DOI
|
19 |
Chung, S. S., Blackshear, J. L., Shen, W. K., Hammill, S. C. and
Gersh, B. J. (2001) Epidemiology and natural history of atrial fibrillation:
clinical implications. J. Am. Coll. Cardiol. 37, 371-378.
DOI
|
20 |
Eun, J. S., Choi, B. H., Park, J. A., Lee, G. I., Lee, T. Y., Kim, D. K.,
Jung, Y. H., Yoo, D. J. and Kwak, Y. G. (2005a) Open channel block
of hKv1.5 by psoralen from Heracleum moellendorffii Hance. Arch.
Pharm. Res. 28, 269-273.
DOI
|
21 |
Eun, J. S., Park, J. A., Choi, B. H., Cho, S. K., Kim, D. K. and Kwak, Y.
G. (2005b) Effects of oxypeucedanin on hKv1.5 and action potential
duration. Biol. Pharm. Bull. 28, 657-660.
DOI
ScienceOn
|